Geuijen C A, Willems R J, Bongaerts M, Top J, Gielen H, Mooi F R
Research Laboratory for Infectious Diseases, National Institute of Public Health and Environment, Bilthoven, The Netherlands.
Infect Immun. 1997 Oct;65(10):4222-8. doi: 10.1128/iai.65.10.4222-4228.1997.
Bordetella pertussis fimbriae are composed of a major subunit, Fim2 or Fim3, and the minor subunit FimD. Using immunoelectron microscopy, we provide evidence that FimD is located at the fimbrial tip. The role of FimD in colonization of the mouse respiratory tract was studied by using two fimbrial mutants: a mutant completely devoid of fimbriae (designated FimD-) and a mutant devoid of the major fimbrial subunits but still producing the minor subunit (designated FimD+). The ability of the two fimbrial mutants to colonize the nasopharynx, trachea, and lungs was compared with those of the wild type parental strain and a filamentous hemagglutinin (FHA) mutant. Of the three mutants studied, the FimD- mutant showed the greatest defect, colonizing less well in the nasopharynx, trachea, and lungs. The most pronounced defect in colonizing ability of the three mutants was observed in the trachea. However, the colonizing defect of the FHA and FimD+ mutants in the trachea was observed only during the first 3 days of infection. After 10 days, the colonization level was nearly restored to wild-type levels. The FHA and FimD+ mutants showed a slight colonization defect in the nasopharynx but no defect in the lungs. A maltose binding protein-FimD fusion protein and a peptide derived from FimD were able to bind to heparin, a member of a class of sulfated sugars which are ubiquitous in the respiratory tract. Recently it was shown (W. L. W. Hazenbos, C. A. W. Geuijen, B. M. van den Berg, F. R. Mooi, and R. van Furth, J. Infect. Dis. 171:924-929, 1995) that FimD also binds to the integrin VLA-5, and our results suggest that the binding of B. pertussis to these two molecules plays an important role in colonization of the respiratory tract of the mouse.
百日咳博德特氏菌菌毛由一个主要亚基Fim2或Fim3以及次要亚基FimD组成。我们通过免疫电子显微镜提供证据表明FimD位于菌毛尖端。利用两种菌毛突变体研究了FimD在小鼠呼吸道定殖中的作用:一种完全没有菌毛的突变体(命名为FimD-)和一种没有主要菌毛亚基但仍产生次要亚基的突变体(命名为FimD+)。将这两种菌毛突变体在鼻咽、气管和肺部定殖的能力与野生型亲本菌株和丝状血凝素(FHA)突变体的能力进行了比较。在所研究的三种突变体中,FimD-突变体表现出最大的缺陷,在鼻咽、气管和肺部的定殖能力较差。在三种突变体中,定殖能力最明显的缺陷出现在气管中。然而,FHA和FimD+突变体在气管中的定殖缺陷仅在感染的前3天观察到。10天后,定殖水平几乎恢复到野生型水平。FHA和FimD+突变体在鼻咽中表现出轻微的定殖缺陷,但在肺部没有缺陷。麦芽糖结合蛋白-FimD融合蛋白和源自FimD的肽能够与肝素结合,肝素是呼吸道中普遍存在的一类硫酸化糖中的一种。最近有研究表明(W. L. W. Hazenbos、C. A. W. Geuijen、B. M. van den Berg、F. R. Mooi和R. van Furth,《传染病杂志》171:924-929,1995年)FimD也能与整合素VLA-5结合,我们的结果表明百日咳博德特氏菌与这两种分子的结合在小鼠呼吸道定殖中起重要作用。